← Leaderboards
Amy Tiersten
New York University School Of Medicine
$19,154
Attributed
$19,154
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $12.6K · FY2005–08$20K$15K$10K$5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$19,154 · 3
By mechanism
M01$19,154 · 3
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Howard S Hochster$9,390,994
- Maarten C Bosland$10,491,195
- Benjamin G. Neel$33,134,772
- Franco M Muggia$5,360,861
- Sally E Blank$145,946
Others in their field
Top investigators on “Ca-125 Antigen”
- Robert C Bast · University Of Texas Md Anderson Can Ctr$20,558,879
- Barbara B O'Brien · Westat, Inc.$11,222,986
- Daniel William Cramer · Brigham And Women'S Hospital$7,375,257
- Anil K Sood · University Of Tx Md Anderson Can Ctr$7,240,800
- William Lake · Information Management Services, Inc.$6,136,501
- Michael Birrer · Clinical Sciences$5,133,568
Research focus
Ca-125 AntigenClinical TrialsComputer Retrieval Of Information On Scientific Projects DatabaseContinuous InfusionDisease ProgressionEnd PointEnrollmentForecast Of OutcomeFundingGrantIn Complete RemissionInstitutionMalignant Neoplasm Of OvaryOxaliplatinPartial ResponseProtocols, TreatmentRateRecurrent DiseaseResearch PersonnelResourcesResponseSourceTopotecanToxic Effect
Grant awards (3)
CLINICAL TRIAL: OXALIPLATIN PLUS TOPOTECAN FOR PATIENTS WITH PREVIOUSLY TREATED$2,708
M01 · FY2008 · RR · contact PI
DOXIL COMBINED WITH DOCETAXEL IN PATIENTS WITH METASTATIC BREAST CANCER$12,626
M01 · FY2006 · RR · contact PI
DOXIL COMBINED WITH DOCETAXEL IN PATIENTS WITH METASTATIC BREAST CANCER$3,820
M01 · FY2005 · RR